Gamabufotalin structure
|
Common Name | Gamabufotalin | ||
|---|---|---|---|---|
| CAS Number | 465-11-2 | Molecular Weight | 402.524 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 595.8±50.0 °C at 760 mmHg | |
| Molecular Formula | C24H34O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 203.4±23.6 °C | |
Use of GamabufotalinGamabufotalin (Gamabufagin), a major bufadienolide of Chansu, has been used for cancer therapy due to its desirable metabolic stability and less adverse effect.IC50 value:Target: in vitro: Gamabufotalin (CS-6) strongly suppressed COX-2 expression by inhibiting the phosphorylation of IKKβ via targeting the ATP-binding site, thereby abrogating NF-κB binding and p300 recruitment to COX-2 promoter. In addition, CS-6 induced apoptosis by activating the cytochrome c and caspase-dependent apoptotic pathway [1]. Gamabufotalin significantly potentiated human breast cancer cells with different status of ER-alpha to apoptosis induction of TRAIL, as evidenced by enhanced Annexin V/FITC positive cells (apoptotic cells), cytoplasmic histone-associated-DNA-fragments, membrane permeability transition (MPT), caspases activation and PARP cleavage [2].in vivo: CS-6 markedly down-regulated the protein levels of COX-2 and phosphorylated p65 NF-κB in tumor tissues of the xenograft mice, and inhibited tumor weight and size [1]. |
| Name | 5-[(3S,5R,8R,9S,10S,11R,13R,14S,17R)-3,11,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one |
|---|---|
| Synonym | More Synonyms |
| Description | Gamabufotalin (Gamabufagin), a major bufadienolide of Chansu, has been used for cancer therapy due to its desirable metabolic stability and less adverse effect.IC50 value:Target: in vitro: Gamabufotalin (CS-6) strongly suppressed COX-2 expression by inhibiting the phosphorylation of IKKβ via targeting the ATP-binding site, thereby abrogating NF-κB binding and p300 recruitment to COX-2 promoter. In addition, CS-6 induced apoptosis by activating the cytochrome c and caspase-dependent apoptotic pathway [1]. Gamabufotalin significantly potentiated human breast cancer cells with different status of ER-alpha to apoptosis induction of TRAIL, as evidenced by enhanced Annexin V/FITC positive cells (apoptotic cells), cytoplasmic histone-associated-DNA-fragments, membrane permeability transition (MPT), caspases activation and PARP cleavage [2].in vivo: CS-6 markedly down-regulated the protein levels of COX-2 and phosphorylated p65 NF-κB in tumor tissues of the xenograft mice, and inhibited tumor weight and size [1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 595.8±50.0 °C at 760 mmHg |
| Molecular Formula | C24H34O5 |
| Molecular Weight | 402.524 |
| Flash Point | 203.4±23.6 °C |
| Exact Mass | 402.240631 |
| PSA | 90.90000 |
| LogP | 1.99 |
| Vapour Pressure | 0.0±3.8 mmHg at 25°C |
| Index of Refraction | 1.612 |
| InChIKey | FMTLOAVOGWSPEF-KJRPADTMSA-N |
| SMILES | CC12CCC(O)CC1CCC1C2C(O)CC2(C)C(c3ccc(=O)oc3)CCC12O |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| (3β,5β,11α)-3,11,14-Trihydroxybufa-20,22-dienolide |
| Gammabufotalin |
| 3b,11a,14-Trihydroxy-5b-bufa-20,22-dienolide |
| Bufa-20,22-dienolide, 3,11,14-trihydroxy-, (3β,5β,11α)- |
| Gamabufotalin |
| (3b,5b,11a)-3,11,14-Trihydroxybufa-20,22-dienolide |
| Gamabufagin |
| Gamabufogenin |